Lixisenatide Reduces BeAM Value (Difference Between Bedtime (Be) and Next-Day Pre-Breakfast (AM) Glucose): A Clinical Indicator for Initiation of Prandial Therapy

Autor:	Woo, Vincent, Shaefer, C., Brath, H., Digenio, A., Lin, Jay, Prasanna Kumar, K.M., Zisman, A.
Zdroj:	In Canadian Journal of Diabetes October 2014 38(5) Supplement:S54-S54
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect